CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation.

CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation.
复制标题

DOI:
10.1007/s11095-013-1252-8
复制
发表时间:
2014-05
影响因子:
3.7
通讯作者:
Amiji, Mansoor M.
Amiji, Mansoor M.
中科院分区:
医学3区
文献类型:
--
作者:
Shah, Lipa;Gattacceca, Florence;Amiji, Mansoor M.

文献摘要

参考文献

被引文献

相似文献

Although neuro-active peptides are highly potent as central nervous system (CNS) therapeutics, their systemic delivery across the blood-brain barrier (BBB) is limited due to lack of permeability in the brain and rapid systemic metabolism. In this study, we aimed at enhancing the brain delivery and stability of chemically modified [D-Arg2, Lys4]-dermorphin-(1-4)-amide)] (DALDA) peptide to achieve prolonged analgesic effects. The C8-DALDA peptide analog was encapsulated in an oil-in-water nanoemulsion formulation made specifically with oils rich in omega-3 rich polyunsaturated fatty acid (PUFA) to enhance CNS availability. The nanoemulsion formulation was administered systemically in CD-1 mice and qualitative and quantitative biodistribution was evaluated. We have also examined the effect of curcumin, which is known to down-regulate efflux transporters and inhibit systemic metabolism, on the pharmacokinetic properties of the peptide. Qualitative and quantitative biodistribution and pharmacokinetic studies in mice clearly demonstrated improved plasma and brain exposure of modified DALDA when administered in nanoemulsion, thereby providing an exciting opportunity towards improved efficacy and/or lowered dose of the peptide. The various dosing regimens tested for modified DALDA solution and curcumin nanoemulsion directed towards a novel combination strategy for improved systemic delivery of peptides across the BBB. Encapsulation of the drug in PUFA nanoemulsions is an effective strategy for delivery of peptides. This work provides a novel combination strategy for improved delivery of peptides to the brain.
DOI: 10.1007/s13346-013-0133-3
发表时间: 2013-08-01
影响因子: 5.4
作者:
Shah, Lipa;Yadav, Sunita;Amiji, Mansoor
通讯作者: Amiji, Mansoor
DOI: 10.1021/mp800240j
发表时间: 2009-05-01
影响因子: 4.9
作者:
Ganta, Srinivas;Amiji, Mansoor
通讯作者: Amiji, Mansoor
DOI: 10.1016/j.ejps.2010.12.005
发表时间: 2011-02-14
影响因子: 4.6
作者:
Navarro, C.;Gonzalez-Alvarez, I.;Bermejo, M.
通讯作者: Bermejo, M.
DOI: 10.1021/jm00123a035
发表时间: 1989-03-01
影响因子: 7.3
作者:
SCHILLER, PW;NGUYEN, TMD;LEMIEUX, C
通讯作者: LEMIEUX, C
DOI: 10.1158/1535-7163.mct-05-0293
发表时间: 2006-01-01
影响因子: 5.7
作者:
Shen, GX;Xu, CJ;Kong, ANT
通讯作者: Kong, ANT